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Summary
The use-dependent modification of synapses is strongly
influenced by dopamine, a transmitter that partici-
pates in both the physiology and pathophysiology of
animal behavior. In the hippocampus, dopaminergic
signaling is thought to play a key role in protein syn-
thesis-dependent forms of synaptic plasticity. The
molecular mechanisms by which dopamine influ-
ences synaptic function, however, are not well under-
stood. Using a GFP-based reporter, as well as a small-
molecule reporter of endogenous protein synthesis,
we show that dopamine D1/D5 receptor activation
stimulates local protein synthesis in the dendrites of
hippocampal neurons. We also identify the GluR1
subunit of AMPA receptors as one protein upregu-
lated by dopamine receptor activation, with increased
incorporation of surface GluR1 at synaptic sites. The
insertion of new GluRs is accompanied by an increase
in the frequency of miniature synaptic events. To-
gether, these data suggest a local protein synthesis-
dependent activation of previously silent synapses as
a result of dopamine receptor stimulation.
Introduction
Dopamine is an important modulator of neuronal func-
tion, critically involved in such diverse behavioral phe-
nomena as motivation, addiction, Parkinson's disease,
and schizophrenia. While the effects of dopamine in ad-
diction and pathology have been the focus of intense
investigation, the mechanisms underlying the dopa-
minergic modulation of glutamatergic synaptic plastic-
ity are poorly understood. Recent experiments impli-
cate the dopaminergic pathway in a variety of learning
and memory tasks, including spatial memory in rats
(Bach et al., 1999), operant conditioning in Aplysia
(Brembs et al., 2002), and working memory in primates
(Castner and Goldman-Rakic, 2004). The molecular
pathways responsible for these effects, however, have
not been identified.
The five known classes of dopamine receptors are
characterized by their G protein-coupled effector mole-
cules; the D1/D5 class is positively coupled to pro-
duction of cyclic adenosine monophosphate (cAMP)
through adenylyl cyclase. The downstream effectors of
cAMP include protein kinase A (PKA) and the cAMP-
responsive element binding protein (CREB), both of*Correspondence: schumane@its.caltech.eduwhich are key players in synaptic plasticity (Lonze and
Ginty, 2002; Nguyen and Woo, 2003; Waltereit and Wel-
ler, 2003). In the hippocampus, D1/D5 receptor activity
is both necessary and sufficient for the maintenance
of late-phase long-term potentiation (L-LTP), a form of
synaptic plasticity associated with learning and mem-
ory (Frey et al., 1991, 1993; Huang and Kandel, 1995;
Matthies et al., 1997; Swanson-Park et al., 1999). L-LTP
also requires protein synthesis, and while there is a
striking similarity in the attenuation of L-LTP by D1/D5
antagonists and protein synthesis inhibitors, a mecha-
nistic relationship between dopamine receptor signal-
ing, protein synthesis, and long-lasting synaptic plas-
ticity has not been described.
Using a green fluorescent protein (GFP) construct as
well as a small-molecule reporter of endogenous pro-
tein translation, we show that D1/D5 receptor activation
stimulates local protein synthesis in the dendrites of
cultured hippocampal neurons. Our work also identifies
the GluR1 subunit of AMPA receptors as one of the pro-
teins upregulated by D1/D5 receptor activation. Impor-
tantly, D1/D5 receptor activation also results in en-
hanced GluR1 insertion at synaptic sites, as revealed
by quantitative immunocytochemistry and whole-cell
electrophysiological recording techniques. We further
show that the increased GluR1 surface expression and
synaptic transmission are blocked by the NMDA recep-
tor antagonist APV, suggesting that dopamine can act
selectively at active synaptic sites.
Results
Because dopaminergic innervation of hippocampal
neurons in vivo originates in the ventral tegmental area,
a region of the brain not included in our culture system,
we first characterized the presence and distribution of
the D1 and D5 dopamine receptors in cultured hippo-
campal neurons. As determined by immunofluores-
cence labeling, both D1 and D5 dopamine receptors
are expressed at moderate levels in the soma and pro-
cesses of mature cultured neurons (Figure 1A). Be-
cause the D1 monoclonal antibody that we used recog-
nizes an extracellular epitope of the D1 receptor, we
were able to examine selectively the surface population
of D1 receptors. There was a significant surface pop-
ulation of these receptors in the cell body and through-
out the dendritic arbor (Figure 1A). We also examined
the colocalization of D1 receptors with a synaptic
marker, bassoon (Sanmarti-Vila et al., 2000; tom Dieck
et al., 1998). There were 38.3 ± 9.6 (mean ± SD) D1
particles per 50 m of dendritic length; on average,
31.7% ± 3.3% of the D1 particles colocalized with bas-
soon staining. These results show that even in the ab-
sence of dopaminergic input, cultured hippocampal
neurons continue to express both D5 and D1 receptors;
a subset of D1 and D5 receptors are in the vicinity of
synapses.
We next examined the ability of SKF-38393, a dopa-
mine D1/D5 receptor agonist (Sibley et al., 1982), to
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766Figure 1. Dopamine D1/D5 Receptor Expression in Cultured Hippocampal Neurons
(A) Shown is the endogenous expression of the D5 class of dopamine receptor. The signal is most prominent in the soma, with moderate
levels of D5 throughout the dendrites. The pseudocolor scale at left indicates fluorescence levels on an 8 bit intensity scale. (B) A dish of
cultured hippocampal neurons labeled in the absence of primary antibody is shown as a control. (C) Surface D1 dopamine receptors were
labeled with an antibody against an extracellular epitope unique to the protein. (D) The area in the yellow box in (C) is shown at high
magnification. Scale bar, 15 (A–C) and 5 m (D).stimulate protein synthesis by visualizing a GFP protein p
tsynthesis reporter molecule (Aakalu et al., 2001) in cul-
tured hippocampal neurons. We compared the levels of m
(GFP signal in control (untreated) neurons to neurons
that had been exposed to bath application of the dopa- w
tmine agonist. Relative to controls, neurons treated with
SKF (100 M for 15 min; Huang and Kandel, 1995) i
fshowed significantly enhanced protein synthesis in
both the soma and dendrites (Figures 2A and 2C). Sim- p
ilar results were obtained with a different D1/D5 recep-
tor agonist, dihydrexidine (DHX; data not shown). The m
lstimulation of protein synthesis by SKF was completely
prevented by the coapplication of a D1/D5 receptor a
pantagonist (SCH-23390, 10 M), confirming that the ob-
served effects were due to dopamine receptor activa- J
etion (Figure 2C). We next examined the onset of SKF-
induced protein synthesis using time-lapse imaging of o
adendrites. Control dendrites exhibited relatively stable
levels of GFP fluorescence over a 60 min imaging aeriod (Figure 2B). In contrast, a brief (15 min) exposure
o SKF increased the GFP signal in dendrites within 60
in (Figures 2B and 2D). In both sets of experiments
i.e., between-dish and time-lapse), the effects of SKF
ere completely prevented by coapplication of the pro-
ein synthesis inhibitor anisomycin (Figures 2C and 2D),
ndicating that the increased fluorescence observed
ollowing D1/D5 receptor activation was due to new
rotein synthesis.
What are the signaling events downstream of dopa-
ine receptor activation that are responsible for stimu-
ating dendritic protein synthesis? In other systems, D1
nd D5 receptor activation is coupled to activation of
rotein kinase A (PKA; Girault and Greengard, 2004;
ay, 2003). We conducted two sets of experiments to
xamine whether PKA might be involved in the present
bservations. First, we examined whether Sp-cAMPS,
n activator of PKA (Scholubbers et al., 1984; Yusta et
l., 1988), affected protein synthesis of the GFP repor-
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767Figure 2. Dopamine D1/D5 Receptor Activation Stimulates Protein Synthesis in Hippocampal Neurons
(A) P2 cultured hippocampal neurons infected with a sindbis virus encoding a GFP reporter. Shown are a control neuron (left) and neurons
imaged 60 min after a 15 min exposure to the D1/D5-selective agonist SKF-38393 (right). Scale bar, 15 m.
(B) Time-lapse images of the dendrites before (top) and 60 min after vehicle or SKF treatment (bottom) are shown in the white box beneath
each F/F plot, which is aligned to the dendrite shown. The control neuron (top panel) showed a small decrease in GFP signal as seen in the
F/F plot for images before and 60 min after vehicle treatment. In contrast, a neuron treated with SKF for 15 min (bottom panel) shows an
overall increase in GFP signal, with small hotspots of high-intensity fluorescence throughout the dendrite.
(C) Box plot (see Experimental Procedures) summary for between-dish experiments (A), showing a significant increase in GFP fluorescence
in the dendrites of SKF-treated neurons relative to control neurons (n = 28 dendrites per condition, p < 0.01). Agonist-induced increases were
prevented by pretreatment with the protein synthesis inhibitor anisomycin (SKF + aniso) or the D1/D5-selective antagonist SCH-23390 (SKF + SCH).
(D) Summary data for time-lapse experiments (B) 60 min after agonist application, showing a significant increase in GFP signal at distances
greater than 75 m from the cell soma (n = 12 dendrites per condition, *p < 0.05). Bar plots show mean ± SEM.
Neuron
768Figure 3. Activation of the PKA Pathway Is
Necessary and Sufficient to Stimulate Pro-
tein Synthesis
(A) Control (left) and Sp-cAMPS-treated (right)
neuron showing that activation of PKA in-
creases synthesis of the GFP reporter; en-
hanced fluorescence is evident in both the
cell body and the dendrites.
(B) Sp-cAMPS-induced increase in GFP syn-
thesis is blocked by the protein synthesis in-
hibitor anisomycin (40 M; left panel); the ef-
fects of the dopamine agonist DHX are
blocked by the coapplication of a protein ki-
nase A inhibitor (right panel).
(C) Box plot summary for experiments shown
in (A) and (B), indicating a significant increase
in GFP fluorescence in the dendrites of Sp-
cAMPS-treated neurons relative to control
neurons (n = 30 dendrites from unique neu-
rons per condition, p < 0.01). Sp-cAMPS-
induced increases were prevented by pre-
treatment with the protein synthesis inhibitor
anisomycin (Sp + aniso; n = 30 dendrites).
DHX-induced increases in dendritic fluores-
cence were blocked by either a PKA inhibitor
(DHX + PKI; n = 30 dendrites) or the transla-
tional inhibitor rapamycin (DHX + Rap; n =
28 dendrites).ter described above. Dendrites from dishes treated with s
rSp-cAMPS (10 M) showed significantly higher levels
of fluorescence than dendrites from control, untreated m
odishes (Figures 3A and 3C). The effects of Sp-cAMPS
were prevented by anisomycin (Figures 3B and 3C). r
tThese results indicate that PKA activation is sufficient
to increase protein synthesis. We next addressed the t
Snecessity of PKA activity in the stimulation of protein
synthesis by the dopamine agonist DHX. We found that p
mthe addition of a membrane-permeant PKA inhibitor
peptide (myristoylated PKI14-22; 200 nM) prevented the l
bDHX-induced increase in dendritic fluorescence, indi-
cating that PKA activity is required (Figures 3B and 3C). l
FLast, we examined whether the dopamine-induced
increase involves stimulation of the mTOR kinase cas- t
bcade (Nguyen, 2002; Tang et al., 2002), a kinase system
implicated in the translation of some mRNAs. We found t
4that the mTOR pathway inhibitor rapamycin (10 nM)
also blocked the stimulatory effects of DHX on protein d
ssynthesis (Figure 3C).
The above data show that dopamine agonists can o
Wstimulate the synthesis of a fluorescent protein synthe-is reporter that contains the 5# and 3# untranslated
egions from α-CaMKII (Aakalu et al., 2001). To deter-
ine whether D1/D5 receptors activate the translation
f endogenous mRNAs in living neurons, we used fluo-
escein-dC-puromycin (F2P), a fluorescent protein syn-
hesis reporter based on the peptidyl transferase inhibi-
or puromycin (Doi et al., 2002; Nemoto et al., 1999;
tarck et al., 2004; Starck and Roberts, 2002). Because
uromycin is a structural analog of an amino-acyl tRNA
olecule, it enters ribosomes actively engaged in trans-
ation, where it becomes covalently attached to the car-
oxy terminus of nascent proteins through a peptide
inkage (Nathans, 1964). Initially, we examined whether
2P can serve as a protein synthesis reporter in cul-
ured hippocampal neurons (Figure 4). A brief (w15 min)
ath application of F2P resulted in fluorescence de-
ected in both the cell body and the dendrites (Figure
A). The majority of the fluorescence observed in the
endrites reflects protein synthesis, as the signal was
ignificantly attenuated by coapplication of anisomycin
r unlabeled puromycin (see Experimental Procedures).
hen neurons were treated with the dopamine agonist
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769Figure 4. A Dopamine Agonist Stimulates
Synthesis of Endogenous Proteins as Indi-
cated by a Puromycin-Based Reporter of
Protein Synthesis
(A) A control neuron incubated for 15 min in
F2P exhibited moderate levels of fluores-
cence, primarily due to basal rates of protein
synthesis in the unstimulated cell. (B) Pre-
treatment with anisomycin blocked a major-
ity of the SKF-induced increase in F2P incor-
poration. (C) Neurons treated with the
dopamine agonist SKF for 15 min in F2P
showed markedly higher fluorescence, with
signal apparent throughout the dendritic ar-
bor. (D) The region boxed in yellow is shown
at high power (right), where F2P signal in the
spines is clearly evident. (E) Box plot sum-
mary showing a significant increase of F2P
signal in SKF-treated neurons. The SKF +
anisomycin condition is significantly dif-
ferent from both the control and SKF condi-
tions (n = 35 dendrites per condition, p <
0.05). Scale bars, 20 (A–C) and 5 m (D).SKF in the presence of F2P, a dramatic stimulation of
protein synthesis in the cell body, dendrites, and spines
was observed (Figures 4C–4E). The increase in F2P sig-
nal elicited by SKF application was completely pre-
vented by coapplication of anisomycin (Figures 4B and
4E). These data indicate that dopamine agonists can
stimulate the synthesis of endogenous protein(s) in hip-
pocampal neurons.
Local, dendritic protein synthesis is required for
some forms of synaptic plasticity (Steward and Levy,
1982; Torre and Steward, 1992; Huber et al., 2000; Kang
and Schuman, 1996; Martin et al., 1997). We directly
examined whether dopamine receptor activation stimu-
lates local protein synthesis by restricting the F2P ap-
plication to a small (3–10 m) region of the dendrite
(Figure 5). Using a red fluorescent dye to monitor thesize and location of the perfusion spot, we locally deliv-
ered a continuous stream of F2P to dendritic regions at
least 100 m from the cell body (Figure 5A). In the ab-
sence of agonist, only low levels of F2P incorporation
were observed in the perfused region (data not shown;
analysis in Figure 5C). Local perfusion of DHX (15 min),
however, caused a dramatic stimulation of local protein
synthesis (Figures 5A and 5C) that was completely pre-
vented when anisomycin was included (Figures 5B and
5C). Because the perfusate was delivered only to a
small region of dendrite, remote from the cell body, the
F2P signal detected was the result of local protein syn-
thesis. These data firmly establish that D1/D5 agonists
stimulate protein synthesis in dendrites.
The above data indicate that dopamine agonists can
stimulate the dendritic synthesis of endogenous pro-
Neuron
770Figure 5. A Dopamine Agonist Stimulates Local Translation of Endogenous Proteins as Indicated by F2P Focal Perfusion
(A) A solution containing dihydrexidine (DHX), F2P, and the dye Alexa 568 (to mark solution flow) was perfused for 15 min onto a small
dendritic segment of a cultured hippocampal pyramidal cell (left; shown is dye spot), resulting in a strong dendritic F2P signal (right). The
high-power image (right, inset) shows high levels of F2P incorporation indicating local protein synthesis in the stimulated dendrite.
(B) Pretreatment and perfusion with a solution containing anisomycin abolished most of the DHX-induced F2P incorporation in the dendrite
(compare high-power insets at right).
(C) The average F2P pixel intensity in each perfused region of interest (ROI, defined by the area of dendrite beneath the Alexa 568 dye) is
shown as a series of box plots. Perfusion of dendrites with DHX resulted in significantly greater F2P incorporation when compared to control
dendrites (p < 0.05). The enhancement produced by DHX was completely blocked by preincubation and perfusion with anisomycin (p < 0.01,
n = 8 dendrites for each condition).
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771teins, but do not establish which particular protein(s)
are the targets of dopamine receptor activation. Since
dopamine has been shown to enhance synaptic trans-
mission at hippocampal synapses (Bouron and Reuter,
1999; Frey et al., 1993; Huang and Kandel, 1995; Ot-
makhova and Lisman, 1996), we considered the possi-
bility that a glutamate receptor subunit might be a
target for dopamine-stimulated translation. We first ex-
amined the effect of dopamine agonist treatment on
synthesis of GluR1 protein detected by 35S labeling and
immunoprecipitation of total GluR1 from cultured hip-
pocampal neuron lysates. Indeed, we found that a brief
exposure to DHX resulted in a significant increase in
GluR1 levels relative to untreated controls detected 30
min after agonist onset (Figures 6A and 6B). In indivi-
dual experiments, we observed an 8%–22% increase
in GluR1 levels following D1/D5 receptor activation
(Figures 6A and 6B). We also examined whether a DHX-Figure 6. Treatment with a Dopamine Agonist
Produces a Protein Synthesis-Dependent
Increase in Total Cellular GluR1
(A) Immunoprecipitation of 35S-labeled GluR1
(top) from hippocampal lysates treated for
30 min with DMSO (control) or dihydrexidine
(DHX). Unprecipitated lysates were reprobed
with an antibody against GluR1 (bottom) for
normalization. (B) A box plot summary of
35S-labeled GluR1 band densities normal-
ized to the corresponding GluR1 band from
cell lysates (control mean = 100%) showed
significantly higher levels of GluR1 protein in
neurons treated with DHX (n = 3, p < 0.01).
(C) DHX-treated neurons showed signifi-
cantly increased levels of total GluR1 protein
as detected in the dendrites by immunofluo-
rescence labeling (n = 12 dendrites per con-
dition, p < 0.05). As shown in the bar graph
summary (D), the effect was blocked by ani-
somycin, with no significant difference de-
tected between control and DHX + aniso
groups. Note the relatively constant magni-
tude of increased GluR1 throughout the en-
tire dendritic length. The pseudocolor scale
ranging from dark blue to white is shown at
bottom left in (B). Scale bar, 15 m. Bar plots
show mean ± SEM.stimulated increase in dendritic GluR1 could be de-
tected in intact dendrites using quantitative immunocy-
tochemistry under permeabilizing conditions. Exposure
to DHX resulted in an increase of approximately 40% in
total GluR1 protein detected 20 min after agonist onset
(Figures 6C and 6D). It is worth noting that this increase
was of a similar magnitude in proximal and distal re-
gions of the dendrite (Figures 6C and 6D).
We next examined whether a dopamine agonist can
alter the population of receptors on the cell surface at
synaptic sites. Using an antibody that recognizes the
GluR1 extracellular domain, we conducted live immu-
nolabeling for surface GluR1 (Figures 7A and 7B, green).
To determine the location of surface-expressed GluR1
relative to synaptic sites, presynaptic compartments
were labeled with an anti-synaptophysin antibody (Fig-
ures 7A and 7B, red). Neurons briefly exposed to DHX
showed a large, anisomycin-sensitive increase in sur-
Neuron
772Figure 7. Dihydrexidine Induces Protein Synthesis-Dependent Increases in Surface Expression of GluR1 at Synaptic Sites
(A) Neurons treated as indicated were immunostained 15 min after agonist exposure under nonpermeabilizing conditions with antibodies
recognizing extracellular epitopes of GluR1 (green) and synaptophysin (red) and are shown as 2D projections. The yellow image (overlap) of
each 2D set represents the colocalization between GluR1 and synaptophysin. Increased surface GluR1 as well as increased colocalization of
GluR1 with synaptophysin is evident in dendrites treated with DHX. Scale bar, 5 m. (B) Representative examples of immunostained dendritic
segments are shown as 3D surface renderings. In these images, all synaptophysin particles are illustrated, whereas only those GluR1 particles
that overlap with synaptophysin are shown. Scale bar, 5 m. (C) Analysis of 3D immunostaining data shows significantly increased surface
GluR1 and GluR1/synaptophysin colocalization in dendrites treated with DHX (n = 15 dendrites per condition, p < 0.01). DHX-induced in-
creases were blocked by anisomycin (p < 0.01), with no significant difference in synaptophysin labeling between groups.face GluR1 detected 15 min after agonist onset (Figures t
a7A–7C and Table 1). This increase was evident in both
the number and average size of GluR1 puncta detected v
ton the surface; the average intensity of GluR1 puncta
was reduced, although this difference failed to reach a
istatistical significance (Table 1). The DHX-stimulated
increase in GluR1 was accompanied by an increase in c
7the overlap of GluR1-positive puncta with synaptophy-
sin (Figures 7A–7C). To analyze the overlap, the number t
aof colocalized (GluR1 and synaptophysin) particles was
divided by the total number of synaptophysin particles; she result estimates the fraction of synaptic sites that
re associated with GluR1 puncta. This analysis re-
ealed that DHX treatment also significantly increased
he colocalization of the surface pool of GluR1 and syn-
ptophysin (Figures 7A–7C). Importantly, the observed
ncrease in colocalization cannot be attributed to a de-
rease in the number of synaptophysin puncta (Figure
C). Both the increased surface GluR1 expression and
he increased synaptic localization were prevented by
nisomycin (Figures 7A–7C), indicating that new protein
ynthesis is required for these changes.
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773Table 1. 3D Particle Analysis Values
3D Particles Analysis Summary Data
Syn Coloc
R1 Num R1 Vol R1 Intensity R1 Total Syn Num Syn Vol Intensity Num Coloc/R1 Coloc/Syn
Control 91.70 20.77 35.60 0.7e5 101.1 65.24 4.0e5 26.70 0.254 0.216
DHX 183.5 33.10 31.93 1.9e5 98.60 61.18 2.8e5 53.30 0.334 0.492
DHX + aniso 111.9 24.34 38.83 1.1e5 97.90 61.34 3.0e5 32.10 0.294 0.227
Statistical Comparison between Groups (ANOVA)
ctrl/DHX * * * * *
DHX/aniso * * * * *
Shown are summary data for the 3D particles analysis on surface GluR1 staining (R1) and synaptophysin (Syn) colocalization (Coloc). The
variables are number of particles (num), mean particle volume (vol), mean pixel intensity per particle (intensity), and integrated pixel intensity
(total). An asterisk in the bottom portion of the table indicates statistical significance at p < 0.05. No significant differences were observed
between the control and DHX + aniso groups.Given the increase in the total and synaptic GluR1
population, we next examined the effects of dopamine
agonists on synaptic transmission. To monitor synaptic
strength before and after exposure to a dopamine ago-
nist, we recorded miniature excitatory postsynaptic
currents (mEPSCs, or minis) in cultured hippocampal
neurons. After a baseline recording period (Figures 8A
and 8B, first trace), neurons were treated with DHX (Fig-
ure 8A) or DHX in the presence of anisomycin (Figure
8B). We observed that DHX induced a rapid increase in
mEPSC frequency that was completely prevented when
protein synthesis was inhibited. On average, DHX in-
duced a 2-fold increase in mEPSC frequency (Figure
8C). There was, however, no change in mEPSC ampli-
tude elicited by the dopamine agonist (Figure 8D). To
determine whether the mEPSC frequency increase was
due to a pre- or postsynaptic mechanism, we included
the membrane-impermeant PKA inhibitor peptide
(PKI6–22) in the recording pipette. Blocking the activity
of PKA postsynaptically completely prevented the
DHX-induced increase in mEPSC frequency (Figure
8C). These data indicate that activation of D1/D5 recep-
tors induces a postsynaptically driven increase in the
frequency, but not amplitude, of mEPSCs.
Taken together, the DHX-induced postsynaptically
driven increase in mini frequency and the increase in
the number of surface GluR1 clusters suggests a po-
tential reduction in the number of postsynaptically “si-
lent” synapses, e.g., those synapses occupied by
NMDA, but not AMPA-type glutamate receptors (Isaac
et al., 1995; Liao et al., 1995, 1999; Petralia et al., 1999).
To examine directly whether dopamine induces an al-
teration in the population of synapses containing only
NMDA versus NMDA + AMPA-type receptors, we con-
ducted double immunocytochemical labeling of sur-
face NMDA receptors (using an antibody that recog-
nizes an extracellular epitope in NR1) and surface
GluR1, comparing receptor populations in control and
DHX-treated dishes (Figure 9). We found that neurons
in DHX-treated dishes had significantly fewer clusters
possessing exclusively NR1 labeling. The DHX-induced
decrease in NR1-only clusters was prevented by aniso-
mycin (40 M), indicating a requirement for protein syn-
thesis. In addition, we noted that DHX also induced a
reduction in the total surface population of NR1; this
reduction in surface NR1 was not blocked by aniso-mycin. These data are consistent with dopamine acti-
vating local protein synthesis to increase the occu-
pancy of previously “silent” receptor sites with GluR1-
containing AMPA receptors.
Is dopamine receptor activity sufficient for the
changes we have described? Given the direct, physical
interaction of dopamine D1 and NMDA receptors (Chen
and Yang, 2002; Harvey and Lacey, 1997; Lee et al.,
2002), we investigated the possibility that NMDA recep-
tor activation plays a role in the D1/D5 agonist-stim-
ulated increases in surface GluR1 and synaptic trans-
mission. We found that a brief preincubation with the
NMDA receptor antagonist APV completely blocked the
DHX-induced increase in surface GluR1 immunoreac-
tivity and colocalization with synaptophysin (Figures
10A and 10B). In addition, APV inhibited the DHX-
induced increase in mEPSC frequency (Figures 10C–
10E), similar to the inhibition observed with anisomycin
or the PKA inhibitor peptide (cf. Figure 8). These results
indicate that dopamine agonists act in concert with en-
dogenous NMDA receptor-mediated synaptic activity
to induce increases in GluR1 surface expression and
synaptic strength.
Discussion
Using both a GFP-based reporter of local translation
and a puromycin-based protein synthesis reporter, we
observed the stimulation of local protein synthesis by
dopamine receptor agonists in the dendrites of cultured
hippocampal neurons. We identify GluR1 as one synap-
tic protein whose synthesis is stimulated by dopamine
receptor activation; dopamine agonists also induced an
increase in surface GluR1, as has been observed in the
nucleus accumbens (Chao et al., 2002; Mangiavacchi
and Wolf, 2004). The agonist-stimulated increase in sur-
face GluR1 required new protein synthesis and in-
creased the fraction of both synaptic sites and NR1
sites that possess a surface GluR1 cluster. The stim-
ulated synthesis and surface expression of GluR1 was
accompanied by a dopamine agonist-stimulated increase
in the frequency, but not amplitude, of mEPSCs.
Is GluR1 Synthesis Local?
Is the increase in GluR1 protein induced by dopamine
agonists the result of local, dendritic translation? Sev-
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Figure 8. A Dopamine Agonist Increased the Frequency, but Not
the Amplitude, of Miniature Excitatory Postsynaptic Currents in a
Protein Synthesis-Dependent Manner s
(A) Whole-cell voltage-clamp recording from a cultured hippocam- i
pal neuron during a baseline period (top) and 10–12 min after bath s
application of dihydrexidine (bottom two traces) showed a rapid L
increase in mini frequency after agonist application. (B) Whole-cell
ivoltage-clamp recording from a neuron pretreated with anisomycin
tfor 30 min showed no difference in mini frequency between the
baseline recording period (top) and 10–12 min after bath applica- w
tion of dihydrexidine (bottom two traces). Scale bar, 10 pA, 333 ms. s
(C) Summary analysis illustrating a 2-fold increase in mini fre- m
quency in neurons treated with dihydrexidine (DHX), which was
tcompletely blocked by preincubation with anisomycin (DHX + an-
siso, n = 10 cells per condition, p < 0.01). Relative frequency is plot-
ted as the mean frequency 10–12 min after agonist application, t
normalized to the mean frequency during the final 2 min of the u
baseline recording period for each experiment. (D) Analysis of mini s
amplitudes showed no significant difference between groups. Nor-
pmalized amplitudes are plotted as the mean amplitude 10–12 min
tafter agonist application, normalized to the mean amplitude during
the final 2 min of the baseline recording period for each experiment. eral recent studies have shown that dendrites possess
he machinery required for the synthesis and trafficking
f membrane proteins (Horton and Ehlers, 2003; Pierce
t al., 2000; Pierce and Lefkowitz, 2001; Torre and
teward, 1996). In addition, the mRNAs for AMPA-type
lutamate receptors have been detected in dendrites
Job and Eberwine, 2001; Ju et al., 2004; Kacharmina
t al., 2000; Steward and Schuman, 2003). Using quan-
itative immunocytochemistry, our analysis revealed a
apid increase in dendritic GluR1 that was detected
ithin 15 min of agonist exposure. When we examined
he different (e.g., proximal versus distal) regions of the
endrites, we found that the increase in GluR1 in the
ost distal aspect of the dendrite was equal to that
bserved in more proximal regions; this observation is
onsistent with a local source of GluR1. In support of
his idea, two other studies have demonstrated that
lutamate receptors can be locally synthesized in den-
rites (Ju et al., 2004; Kacharmina et al., 2000).
hanges in Surface GluR1—Conversion
f Postsynaptically Silent Synapses?
e also observed a protein synthesis-dependent in-
rease in GluR1 detected on the plasma membrane of
yramidal neurons, which has been previously de-
cribed in cultured medium spiny neurons and inter-
eurons of the nucleus accumbens (Chao et al., 2002;
angiavacchi and Wolf, 2004). The increased surface
luR1 included both an increase in the number of sur-
ace GluR1 puncta detected, as well as an increase in
he average size of the surface puncta. The average
ntensity of the puncta was not significantly changed.
he increase in surface GluR1 resulted in a greater co-
ocalization of the GluR1 population with a synaptic
arker and with surface-labeled NR1. The increase in
he number of GluR1 puncta together with the de-
reased number of NR1-only sites fits well with the ob-
erved increase in mini frequency. We were surprised
hat the increase in GluR1 puncta size was not accom-
anied by an increase in mini amplitude. It is possible
hat the increase in puncta size may be due to a
preading of GluR1 patches, rather than a physiologi-
ally meaningful increase in receptor number at preex-
sting sites. The small decrease in average GluR1 inten-
ity is perhaps consistent with this view. Alternatively,
f, prior to DHX application, glutamate receptors are not
aturated by the quantal release of transmitter (e.g.,
iu, 2003), then the addition of more receptors to preex-
sting receptor sites might not be expected to increase
he mini amplitude. Our experiments do not address
hether the protein synthesis dependence of the ob-
erved increase in surface GluR1 reflects the require-
ent for new GluR synthesis, or, alternatively, the syn-
hesis of other proteins that favor the trafficking or
tabilization of GluR1 on the surface. Taken together,
hese data suggest that D1/D5 receptor activation stim-
lates a local protein synthesis-dependent increase in
urface GluR1 at synaptic sites that did not previously
ossess functional postsynaptic GluRs, consistent with
he activation of postsynaptically silent synapses (Isaac
t al., 1995; Liao et al., 1995, 1999; Petralia et al., 1999).
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(A) Representative examples of immunostained dendritic segments are shown as 3D surface renderings. In these images, all NR1 surface
particles are illustrated, whereas only those GluR1 particles that overlap with NR1 are shown. Scale bar, 5 m. (B) Analysis of 3D immuno-
staining data shows DHX significantly increased surface GluR1 and surface GluR1/surface NR1 colocalization (n = 28 dendrites per condition,
p < 0.01). DHX-induced increases were blocked by anisomycin (p < 0.01). DHX also induced a decrease in surface NR1 that was not blocked
by anisomycin.Rapid Changes in Synaptic Strength
As has been observed by others (Bouron and Reuter,
1999), we found that the application of a dopamine re-
ceptor agonist (DHX) to cultured hippocampal neurons
caused a rapid (e.g., within 10 min) increase in mini fre-
quency without changing mini amplitude. Surprisingly,
the DHX-stimulated increase in mini frequency was
blocked by a brief pretreatment with a protein synthesis
inhibitor. These results suggest that dopamine stimu-
lates dendritic protein synthesis, the protein products
of which contribute to a postsynaptically driven
increase in mini frequency. It is possible that the ob-
served effects are due, at least in part, to the dopa-
mine-stimulated increases in surface GluRs. While the
previous study (Bouron and Reuter, 1999) attributed the
increase in mini frequency to enhanced glutamate re-
lease, the pre- versus postsynaptic locus of the effect
was not characterized. In contrast, our observation that
inclusion of a membrane-impermeant PKA inhibitor in
the (postsynaptic) recording pipette blocks the DHX-
induced increase in mini frequency supports the idea
that dopamine increases mini frequency through a
postsynaptic mechanism. We recently reported (Sutton
et al., 2004) that minis themselves can regulate local pro-
tein synthesis. The dopamine agonist-induced increase
in mini frequency described here is predicted to inhibitfuture local protein synthesis, providing a potentially ef-
fective negative regulatory feedback loop.
NMDAR-Dopamine Connection
It is becoming increasingly clear that there is a connec-
tion between dopaminergic and glutamatergic systems
in the brain circuits that subserve reward, learning, and
drug addiction (Beninger and Miller, 1998; Berke and
Hyman, 2000; Herberg and Rose, 1990; Howland et al.,
2002; Jay, 2003; Wolf et al., 2003). We found that NMDA
receptor activity is required for the (protein synthesis-
dependent) DHX-induced increases in both surface
GluR and mini frequency. It is worth noting that the
NMDA receptor activity required in our experiments
must arise from spontaneous neurotransmitter release.
In considering the diffuse and long-lasting nature of
physiologically released dopamine signals in the brain,
the requirement for NMDA receptor activity suggests
the possibility that only active, potentially NMDAR-only,
synapses will exhibit the dopamine-elicited changes in
GluR expression and synaptic strength.
Implications for Synaptic Plasticity
Our data provide a potential cellular mechanism for the
dopaminergic modulation of long-lasting plasticity at
hippocampal synapses. Others have reported that do-
Neuron
776Figure 10. The Effects of Dopamine Agonists Require NMDA Receptor Activity
(A) Shown are 3D reconstructions of surface labeled GluR1 (green) and synaptophysin (red) in dendrites treated with DMSO (control), DHX,
or DHX + APV. As in Figure 6B, reconstructed images illustrate total synaptophysin signal, and only the GluR1 puncta that colocalize with
synaptophysin. Scale bar, 5 m. (B) Summary analysis of 3D immunolabeling experiments showed that increased surface GluR1 and increased
GluR1/synaptophysin colocalization were blocked by pretreatment with APV (n = 18 dendrites per condition, p < 0.01). (C–E) The DHX-
induced increases in mini frequency (C) were significantly reduced in the presence of APV (n = 8 cells per condition, p < 0.05) (D). For each
experiment, a sample trace from the baseline period is shown, followed by two traces selected from the 10–12 min time point after drug
application. Scale bar, 10 pA, 400 ms.pamine or activators of the cAMP/PKA pathway can g
linduce a long-lasting protein synthesis-dependent form
of potentiation in hippocampal slices (Frey et al., 1993; s
Huang and Kandel, 1995). It has also been shown that
L-LTP is diminished in hippocampal slices treated with E
dopamine receptor antagonists (Frey et al., 1990, 1991;
CSwanson-Park et al., 1999) or prepared from D1 recep-
Dtor knockout mice (Matthies et al., 1997). In addition, a
a
PKA-dependent increase in GluR1 synthesis has been f
observed during the late (3 hr postinduction) phase of a
gLTP (Nayak et al., 1998). The data presented here sug-est that dopamine exerts its effects on plasticity, at
east in part, by local regulation of protein synthesis and
ynaptic GluR expression.
xperimental Procedures
ultured Hippocampal Neurons
issociated hippocampal neurons were prepared and maintained
s previously described (Aakalu et al., 2001). Briefly, hippocampi
rom postnatal day 2 Sprague-Dawley rat pups were enzymatically
nd mechanically dissociated and plated into poly-lysine-coated
lass-bottom petri dishes (Mattek). Neurons were maintained for
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77714 to 21 days at 37°C in growth medium (Neurobasal A supple-
mented with B27 and Glutamax-1, Invitrogen).
Microscopy and Image Analysis
All images were acquired with a Zeiss 510 Meta or an Olympus IX-
70 confocal laser scanning microscope. GFP, Alexa 488, and F2P
were excited with the 488 nm line of an argon ion laser, and emitted
light was collected between 510 and 550 nm. Alexa 568 was ex-
cited with the 568 nm line of a krypton ion laser, and emitted light
was collected above 600 nm. In experiments where two channels
were acquired simultaneously, settings were chosen to ensure no
signal bleed-through between channels. For between-dish com-
parisons on a given day, all images were acquired at the same
settings, without knowledge of the experimental condition during
image acquisition. All postacquisition processing and analysis was
carried out with ImageJ (NIH) and Matlab (The MathWorks, Inc.). To
facilitate the analysis of fluorescence signal as a function of dis-
tance from the soma, dendrites were linearized and extracted from
the full-frame image using a modified version of the Straighten
plugin for ImageJ.
In time-lapse experiments, dendrites were analyzed as follows:
fluorescence was averaged across the width of linearized den-
drites, generating a vector of mean pixel intensities equal to the
length of the dendrite. F/F (Ftn − Ft0/Ft0) was then computed at
each pixel along the dendritic length. A value of 1 was added to
every pixel in the linearized dendrite image, to a maximum of 255,
which sets the minimum mean pixel intensity across the width of
the dendrite equal to 1. This prevents artificially large F/F values
that result from fractional mean pixel values due to zeros in the
initial image. For time-lapse summary data, the sum of F/F values
in 75 m bins was computed for each dendrite, and the mean ±
standard error for all dendrites in a given experimental condition
was plotted. 3D colocalization and particle analysis was performed
using custom-written functions in Matlab. Of particular concern in
such measurements is the issue of selecting appropriate threshold
values to isolate the punctate data of interest from background
noise in the raw images. In order to avoid potential biases in select-
ing thresholds, we have relied on the “graythresh” command in
Matlab. This function generates an optimal threshold based on Os-
tu's method, which sets a threshold that minimizes the intraclass
variance of the black and white pixels. To further ensure that the
experimental effects we observed were robust to threshold set-
tings, the colocalization and particle analysis was performed with
a series of 7 to 11 thresholds, using the output of graythresh as the
median threshold value. All reported results were unaffected by
such a range of threshold settings.
Box Plots
Box plots were used because they capture a number of properties
about the distribution of the data in a single graph. In each box
plot, the red line indicates the median of the data, the diagonal
lines leading away from the median (notches) are robust estimates
of the uncertainty (or error) about the median, the horizontal lines
of the box show the interquartile range, and the vertical “whiskers”
with endcaps represent the entire extent of the data. In general, a
visual comparison of data shown in a box plot can be used to
determine statistical significance by comparing the notches be-
tween groups; if the notches do not overlap, the two data sets are
significantly different from one another.
GFP Experiments
The GFP construct and Sindbis virus used were described pre-
viously (Aakalu et al., 2001). Neurons 14–21 days in vitro were in-
fected for 15–20 min with the virus and allowed to incubate for
12–14 hr at 37°C before imaging commenced. After the incubation
period, cells were transferred from growth medium into a HEPES-
based imaging medium (HBS), containing 119 mM NaCl, 5 mM KCl,
2 mM CaCl2·2H20, 2 mM MgCl2·6H20, 30 mM glucose, and 20 mM
HEPES (pH = 7.4). Dishes were maintained at 37°C in HBS for a
minimum of 1 hr prior to imaging. For between-dish experiments
(Figures 2A and 3), neurons were treated for 15–20 min with the
following agonists at the indicated concentrations: SKF-38393 (100
M, Sigma); dihydrexidine (10 M, Tocris); Sp-cAMPS (10 M,Sigma). For antagonist experiments, cells were preincubated in the
following drugs before agonist treatment at the indicated times and
concentrations: anisomycin (20 min, 40 M, Sigma); rapamycin (1
hr, 10 nM, Cell Signaling Technology); myristoylated PKI14–22 (30
min, 200 nM, Sigma); SCH-23390 (30 min, 10 M, Sigma). After
drug treatment, dishes were rinsed with HBS, incubated at 37°C
for an additional 45 min, and then fixed in 4% formaldehyde/4%
sucrose for 20 min at 4°C. Protein synthesis inhibitors and the vari-
ous receptor and kinase antagonists were left on for the entire incu-
bation period. For time-lapse experiments (Figure 2B), three base-
line images were acquired at 30 min intervals before drug treatment
in order to ensure relatively stable fluorescence in unmanipulated
neurons. At time t = 0, neurons were treated for 15 min with HBS
(control) or 100 M SKF. The next image (t = 30 min) was acquired
15 min after drug washout, and images were acquired every 30
min thereafter. Neurons were maintained at 37°C between imaging
periods, with image acquisition periods lasting no longer than 3
min at room temperature. In an effort to control for possible non-
specific mechanical effects of adding or removing solution from the
dishes, the number of solution exchanges was held constant
across all experimental conditions.
F2P Experiments
Fluorescein-dC-puromycin was synthesized using standard phos-
phoramidite chemistry at the California Institute of Technology oli-
gonucleotide synthesis facility and desalted via OPC cartridge
chromatography (Glen Research) and on Sephadex G-10 (Sigma).
For bath-application experiments, F2P was added to HBS for a
final working concentration of 40–60 M. Cells were preloaded with
F2P for 5 min and then incubated in SKF (100 M) or HBS (control)
for 15 min in the presence of F2P at 37°C. Free F2P was washed
out with 4 × 2 ml of HBS before neurons were fixed for fluorescence
microscopy. Local perfusion experiments were done for 15–20 min
without preloading the neurons with F2P. Flow rates were manually
regulated using syringes attached to patch pipettes. There was no
significant difference in perfusion spot size between groups (data
not shown). In experiments using anisomycin to inhibit F2P incor-
poration, equimolar concentrations of anisomycin were added to
the neurons 30 min before and for the entire duration of the experi-
ment. Anisomycin or puromycin signficantly reduced the F2P signal
in control (unstimulated) neurons by about 65% and completely
abolished the increase in F2P signal observed following stimulation
(Figure 4).
Immunocytochemistry and 35S-Labeling Experiments
For surface GluR1/synaptophysin colocalization experiments, cul-
tured neurons were pretreated for 20 min at 37°C with DMSO or 40
M anisomycin and then treated for 15 min at 37°C with DMSO
(control), 10 M dihydrexidine (DHX), or DHX + anisomycin. Immu-
nolabeling of cultured hippocampal neurons to detect total as well
as surface GluR1 was done as previously described (Patrick et al.,
2003; Richmond et al., 1996). For GluR1 and NR1 surface-labeling
experiments, neurons were live labeled for 10–15 min at 37°C with
an antibody against the extracellular domain of GluR1 and/or NR1
immediately following drug treatment, and then fixed and pro-
cessed for immunocytochemistry using conventional techniques.
To identify the surface D1 population, neurons were fixed under
nonpermeabilizing conditions and labeled with an antibody against
an extracellular epitope of the D1 dopamine receptor. Identification
of D5 immunoreactivity was performed under permeabilized condi-
tions, as there is no commercially available antibody that recog-
nizes an extracellular epitope of the D5 receptor. For 35S labeling
experiments, ten dishes of high-density neurons were used for
each experimental condition. Dishes were incubated in HBS (con-
taining no amino acids) for 1 hr prior to treatment with DMSO (con-
trol) or 10 M DHX for 30 min at 37°C in 1 ml of HBS containing 20
Ci 35S met/cys. A total of three experiments were analyzed, using
30 dishes from three different preps of neurons for each condition.
Inclusion of a protein synthesis inhibitor completely abolishes the
35S label. The following antibodies were used: mouse anti-dopa-
mine D1 receptor monoclonal antibody for surface labeling (1:50,
Chemicon), mouse anti-dopamine D5 monoclonal antibody (1:300,
Chemicon), rabbit anti-GluR1 N-terminal domain for surface label-
Neuron
778ing (1:10, EMD Biosciences), mouse anti-NR1 extracellular domain D
Yfor surface labeling (1:20, Affinity Bio Reagents), rabbit anti-GluR1
for IP (1:1000, Upstate), mouse anti-synaptophysin (1:1000, Sigma), g
amouse anti-bassoon (1:1000, StressGen), goat anti-mouse Alexa
568 (1:1000), goat anti-mouse Alexa 546 (1:1000), goat anti-rabbit n
Alexa 488 (1:1000, Molecular Probes). F
t
Whole-Cell Recordings C
Whole-cell recordings in voltage-clamp mode were performed F
on cultured neurons 14–21 days in vitro using a whole-cell solu- p
tion containing 100 mM gluconic acid, 0.2 mM EGTA, 5 mM p
MgCl2·6H20, 40 mM HEPES, 2 mM Mg ATP, and 0.3 mM Li GTP (pH N
adjusted to 7.2 with CsOH). Cells were held at a membrane poten-
Ftial of −60 to −65 mV with holding currents that did not exceed −25
upA. Baseline recordings from cells were acquired for 5–8 min for
2each cell, and then for at least 12 min following drug application.
GFor anisomycin experiments, cells were pretreated with 40 M an-
miso for 30–45 min, and anisomycin was added to the recording pi-
pette. To block NMDA receptors, cells were pretreated with 50 M H
APV for 20–30 min, which was left on the cells for the duration of t
the experiment. The PKI6–22 peptide was used at 20 M in the i
patch pipette. Neither anisomycin nor PKI6–22 significantly affected N
baseline frequency or amplitude (data not shown). Recordings in H
which the series resistance changed by greater than 15% were w
excluded from analysis.
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